heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with rivastigmine in 2 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (rivastigmine) | Trials (rivastigmine) | Recent Studies (post-2010) (rivastigmine) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 1,397 | 266 | 633 |
| Protein | Taxonomy | heptakis(2,6-o-dimethyl)beta-cyclodextrin (IC50) | rivastigmine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 6.2943 | |
| Cholinesterase | Homo sapiens (human) | 1.1886 | |
| Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | 1.71 | |
| Acetylcholine receptor subunit epsilon | Rattus norvegicus (Norway rat) | 9 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.875 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.875 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 3.9833 | |
| Acetylcholinesterase | Homo sapiens (human) | 2.8567 | |
| Acetylcholinesterase | Bos taurus (cattle) | 0.62 | |
| Cholinesterase | Canis lupus familiaris (dog) | 6.27 | |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | 3.5012 | |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | 0.16 | |
| Beta-secretase 1 | Homo sapiens (human) | 7.72 | |
| Cholinesterase | Equus caballus (horse) | 2.1636 | |
| Cholinesterase | Mus musculus (house mouse) | 0.829 | |
| Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | 5.2767 | |
| Carboxylic ester hydrolase | Equus caballus (horse) | 0.495 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degim, Z; Eşsiz, D; Mutlu, NB; Nacar, A; Yilmaz, S | 2 |
2 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and rivastigmine
| Article | Year |
|---|---|
Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).
Topics: Absorption; Animals; beta-Cyclodextrins; Biological Transport, Active; Brain; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Drug Compounding; Excipients; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2010 |
New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Topics: Alzheimer Disease; Animals; beta-Cyclodextrins; Biological Availability; Brain; Cell Line; Cholinesterase Inhibitors; Dogs; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Neuroprotective Agents; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2011 |